Cheshire, UK -- (MARKET WIRE) -- 12/22/2005 -- : Protherics PLC (“Protherics”), the biopharmaceutical company focused on critical care and oncology, announces the award, on 21 December 2005, of a conditional right to receive 72,380 ordinary shares in the Company under the Protherics PLC 2005 Long Term Incentive Plan (the “LTIP”), to Saul Komisar, President of the Company’s US operations. The award vests on the third anniversary of the date of grant subject to the achievement of the performance conditions. Following the above award, Saul Komisar holds conditional awards over 172,631 ordinary shares in the Company under the LTIP and options over 551,629 ordinary shares granted under the Protherics PLC Unapproved Executive Share Option Scheme. Protherics PLC also announces the grant, under the LTIP, of the following options over 2p ordinary shares in the Company, on 21 December 2005: More...
